FILE PHOTO: The Haleon factory in Suzhou, Jiangsu Province, China, March 10, 2026. REUTERS/Go Nakamura/File Photo

Consumer health maker Haleon has lifted sales 24% per store in the United States by placing digestive aids next to weight-loss drugs. The strategy capitalizes on soaring demand for GLP-1 treatments that treat obesity.